IDF's anthrax vaccine trial "violated Helsinki Convention"
Siegel-Itzkovich, J.
Bmj 338: B1325
2009
ISSN/ISBN: 0959-8138 PMID: 19332445 Document Number: 630802
Document emailed within 1 workday
Related Documents
Kaufmann, A.F.; Fox, M.D.; Kolb, R.C. 1973: Anthrax in Louisiana, 1971: an evaluation of the Sterne strain anthrax vaccine Journal of the American Veterinary Medical Association 163(5): 442-445Sadoyoĭ, N.V.; Derbin, M.I.; Garin, N.S.; Tarumov, V.S.; Mikhaĭlov, V.V. 1979: Isolation and study of an anthrax protective antigen. V. the dynamics of immunity in vaccination with a concentrated, purified sorbed chemical anthrax vaccine Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 5: 64-67
Glowka, L 2000: Complementarities between the convention on migratory species and the convention on biological diversity Journal of International Wildlife Law and Policy 3(3): 205-252
Romanov, G.I. 1980: Preparation, control and application of anthrax vaccine in USSR Archiv für Experimentelle Veterinarmedizin 34(1): 119-122
Nosten, F.; Luxemburger, C.; Kyle, D.E.; Ballou, W.R.; Wittes, J.; Wah, E.; Chongsuphajaisiddhi, T.; Gordon, D.M.; White, N.J.; Sadoff, J.C.; Heppner, D.G. 1996: Randomised double-blind placebo-controlled trial of SPf66 malaria vaccine in children in northwestern Thailand. Shoklo SPf66 Malaria Vaccine Trial Group Lancet 348(9029): 701-707
Aida, T. 1979: Pages for ILO: how will we advance the campaign in present situation, aiming at the ratification of the ILO Nursing Personnel Convention? Convention on the foundation of daily practice of nursing Japanese Journal of Nursing 31(4): 115-117
Aida, T. 1979: Pages for ILO: how will we advance the campaign in present situation, aiming at the ratification of the ILO Nursing Personnel Convention? Convention on the foundation of daily practice of nursing Japanese Journal of Nursing 31(4): 115-117
Gilson, R.T.; Schissel, D.J. 2004: Recurrent, localized urticaria and erythema multiforme: a review and management of cutaneous anthrax vaccine-related events Cutis 73(5): 319-325
Abalakin, V.A.; Cherkasskiĭ, B.L. 1986: Hereditary resistance to anthrax and sensitivity to the anthrax toxin in mice Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 5: 45-49
Cymet, T.C.; Kerkvliet, G.J. 2002: Follow-up on "Symptoms associated with anthrax exposure: suspected 'aborted' anthrax" Journal of the American Osteopathic Association 102(4): 203
Wilhelmson, B. 1993: Trial and error for pertussis vaccine. Does the new recombinant vaccine have superior qualities? Lakartidningen 90(26-27): 2458-2459
Andrasik, M.P.; Sesay, F.Albertina.; Isaacs, A.; Oseso, L.; Allen, M. 2020: Social Impacts among Participants in HIV Vaccine Trial Network (HVTN) preventive HIV vaccine trials Journal of Acquired Immune Deficiency Syndromes 2020
Vaccari, M.; Poonam, P.; Franchini, G. 2010: Phase IIi HIV vaccine trial in Thailand: a step toward a protective vaccine for HIV Expert Review of Vaccines 9(9): 997-1005
Schmitt-Grohé, S.; Stehr, K.; Cherry, J.D.; Heininger, U.; Uberall, M.A.; Laussucq, S.; Eckhardt, T. 1997: Minor adverse events in a comparative efficacy trial in Germany in infants receiving either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP (DTP) or DT vaccine. The Pertussis Vaccine Study Group Developments in Biological Standardization 89: 113-118
Bakari, M.; Munseri, P.; Francis, J.; Aris, E.; Moshiro, C.; Siyame, D.; Janabi, M.; Ngatoluwa, M.; Aboud, S.; Lyamuya, E.; Sandström, E.; Mhalu, F. 2013: Experiences on recruitment and retention of volunteers in the first HIV vaccine trial in Dar es Salam, Tanzania - the phase I/Ii HIVIS 03 trial Bmc Public Health 13: 1149
Lindsey, J.C.; Shah, S.K.; Siberry, G.K.; Jean-Philippe, P.; Levin, M.J. 2013: Ethical tradeoffs in trial design: case study of an HPV vaccine trial in HIV-infected adolescent girls in lower income settings Developing World Bioethics 13(2): 95-104
Kintu, K.; Andrew, P.; Musoke, P.; Richardson, P.; Asiimwe-Kateera, B.; Nakyanzi, T.; Wang, L.; Fowler, M.G.; Emel, L.; Ou, S.-S.; Baglyos, L.; Gurunathan, S.; Zwerski, S.; Jackson, J.B.; Guay, L. 2013: Feasibility and safety of ALVAC-HIV vCP1521 vaccine in HIV-exposed infants in Uganda: results from the first HIV vaccine trial in infants in Africa Journal of Acquired Immune Deficiency Syndromes 63(1): 1-8
Wheeler, C.M.; Castellsagué, X.; Garland, S.M.; Szarewski, A.; Paavonen, J.; Naud, P.; Salmerón, J.; Chow, S.-N.; Apter, D.; Kitchener, H.; Teixeira, J.úl.C.; Skinner, S.R.; Jaisamrarn, U.; Limson, G.; Romanowski, B.; Aoki, F.Y.; Schwarz, T.F.; Poppe, W.A.J.; Bosch, F.X.; Harper, D.M.; Huh, W.; Hardt, K.; Zahaf, T.; Descamps, D.; Struyf, F.; Dubin, G.; Lehtinen, M.; Denham, I.; Garland, S.M.; Mindel, A.; O'Sullivan, M.; Skinner, S.R.; Waddell, R.; De Sutter, P.; Poppe, W.A.J.; Tjalma, W.; De Carvalho, N.S.; Naud, P.; Teixeira, J.C.; Aoki, F.Y.; Diaz-Mitoma, F.; Dionne, M.; Ferguson, L.; Miller, M.; Papp, K.; Ramjattan, B.; Romanowski, B.; Somani, R.; Apter, D.; Karppa, T.; Kudjoi, N.; Kyha-österlund, L.; Lehtinen, M.; Levanen, H.; Lönn 2012: Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial LANCET. Oncology 13(1): 100-110
Blesch, G. 2008: Judge overrules CMS. HHS violated Medicare bad-debt policy Modern Healthcare 38(23): 12-13
Dane, D.S.; Dick, G.W.A.; Connolly, J.H.; Fisher, O.D.; McKeown, F.; Briggs, M.; Nelson, R.; Wilson, D. 1957: Vaccination Against Poliomyelitis with Live Virus Vaccines: 1. a Trial of TN Type Ii Vaccine. 2. a Trial of SM Type i Attenuated Poliomyelitis Virus Vaccine. 3. the Evaluation of TN and SM Virus Vaccines BMJ 1(5010): 59-74